vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $104.1M, roughly 1.9× GRID DYNAMICS HOLDINGS, INC.). GRID DYNAMICS HOLDINGS, INC. runs the higher net margin — -1.4% vs -14.6%, a 13.2% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 3.7%). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 12.0%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
AXSM vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $104.1M |
| Net Profit | $-28.6M | $-1.5M |
| Gross Margin | — | 34.8% |
| Operating Margin | -13.8% | 61.7% |
| Net Margin | -14.6% | -1.4% |
| Revenue YoY | 65.0% | 3.7% |
| Net Profit YoY | 61.9% | -150.6% |
| EPS (diluted) | $-0.55 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $196.0M | $106.2M | ||
| Q3 25 | $171.0M | $104.2M | ||
| Q2 25 | $150.0M | $101.1M | ||
| Q1 25 | $121.5M | $100.4M | ||
| Q4 24 | $118.8M | $100.3M | ||
| Q3 24 | $104.8M | $87.4M | ||
| Q2 24 | $87.2M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $-28.6M | $306.0K | ||
| Q3 25 | $-47.2M | $1.2M | ||
| Q2 25 | $-48.0M | $5.3M | ||
| Q1 25 | $-59.4M | $2.9M | ||
| Q4 24 | $-74.9M | $4.5M | ||
| Q3 24 | $-64.6M | $4.3M | ||
| Q2 24 | $-79.3M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | -13.8% | 0.5% | ||
| Q3 25 | -27.0% | -0.2% | ||
| Q2 25 | -24.5% | -0.1% | ||
| Q1 25 | -46.9% | -2.0% | ||
| Q4 24 | -61.1% | 1.3% | ||
| Q3 24 | -59.8% | 2.4% | ||
| Q2 24 | -89.5% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | -14.6% | 0.3% | ||
| Q3 25 | -27.6% | 1.1% | ||
| Q2 25 | -32.0% | 5.2% | ||
| Q1 25 | -48.9% | 2.9% | ||
| Q4 24 | -63.1% | 4.5% | ||
| Q3 24 | -61.7% | 4.9% | ||
| Q2 24 | -91.0% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $-0.55 | $0.01 | ||
| Q3 25 | $-0.94 | $0.01 | ||
| Q2 25 | $-0.97 | $0.06 | ||
| Q1 25 | $-1.22 | $0.03 | ||
| Q4 24 | $-1.54 | $0.06 | ||
| Q3 24 | $-1.34 | $0.05 | ||
| Q2 24 | $-1.67 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $327.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $530.1M |
| Total Assets | $689.8M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $322.9M | $342.1M | ||
| Q3 25 | $325.3M | $338.6M | ||
| Q2 25 | $303.0M | $336.8M | ||
| Q1 25 | $300.9M | $325.5M | ||
| Q4 24 | $315.4M | $334.7M | ||
| Q3 24 | $327.3M | $231.3M | ||
| Q2 24 | $315.7M | $256.0M |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $88.3M | $542.1M | ||
| Q3 25 | $73.7M | $537.7M | ||
| Q2 25 | $73.1M | $532.2M | ||
| Q1 25 | $53.2M | $517.4M | ||
| Q4 24 | $57.0M | $517.8M | ||
| Q3 24 | $92.9M | $400.2M | ||
| Q2 24 | $102.9M | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $689.8M | $612.9M | ||
| Q3 25 | $669.3M | $613.2M | ||
| Q2 25 | $639.8M | $608.9M | ||
| Q1 25 | $596.7M | $590.9M | ||
| Q4 24 | $568.5M | $592.2M | ||
| Q3 24 | $561.5M | $477.3M | ||
| Q2 24 | $548.2M | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | — |
| Free Cash FlowOCF − Capex | $-18.7M | — |
| FCF MarginFCF / Revenue | -9.6% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $9.9M | ||
| Q3 25 | $1.0M | $7.0M | ||
| Q2 25 | $-32.4M | $14.4M | ||
| Q1 25 | $-43.4M | $9.4M | ||
| Q4 24 | $-26.2M | $7.1M | ||
| Q3 24 | $-18.6M | $9.2M | ||
| Q2 24 | $-30.1M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | $6.1M | ||
| Q3 25 | $988.0K | $2.9M | ||
| Q2 25 | $-32.4M | $10.2M | ||
| Q1 25 | $-43.7M | $6.0M | ||
| Q4 24 | $-26.2M | $4.4M | ||
| Q3 24 | $-18.7M | $5.9M | ||
| Q2 24 | $-30.2M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | 5.7% | ||
| Q3 25 | 0.6% | 2.8% | ||
| Q2 25 | -21.6% | 10.1% | ||
| Q1 25 | -36.0% | 6.0% | ||
| Q4 24 | -22.1% | 4.4% | ||
| Q3 24 | -17.9% | 6.8% | ||
| Q2 24 | -34.6% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.6% | ||
| Q3 25 | 0.0% | 3.9% | ||
| Q2 25 | 0.0% | 4.1% | ||
| Q1 25 | 0.3% | 3.3% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.1% | 3.7% | ||
| Q2 24 | 0.1% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | — | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
